Rating Change
Piper Sandler reiterated its Overweight rating on Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) on August 11, 2026.
reiterateNASDAQ:OBIO
Piper Sandler Reiterates Overweight Rating on Orchestra BioMed Holdings, Inc. (OBIO)
Piper Sandler reiterated its Overweight rating on Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) on August 11, 2026.
At publication ·
What changed
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) · reiterate
- Firm
- Piper Sandler
- Rating
- Overweight to Overweight
- Price at event
- $4.43
- Market capitalization
- $257.8M
At a glance
Key takeaways
- Piper Sandler reiterated an Overweight rating on Orchestra BioMed Holdings (OBIO) on August 11, 2026, with the stock trading at $4.42 and a market capitalization of $257.8 million.
Market Context
Orchestra BioMed Holdings, Inc. operates in the Healthcare sector. The stock currently trades at $4.42 with a market capitalization of $257.8M. The stock has gained 71.5% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Orchestra BioMed Holdings, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Orchestra BioMed Holdings, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | Piper Sandler | Overweight | N/A |
| May 19, 2026 | B. Riley Securities | Buy | N/A |
| May 14, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 13, 2026 | Barclays | Overweight | N/A |
| Mar 12, 2026 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View OBIO Stock Page
Frequently Asked Questions
What does the Overweight rating mean for OBIO?
A rating of Overweight from Piper Sandler reflects the analyst's outlook on Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OBIO forecast page.